welcome back solagran, page-6

I'm here, but nothing much has changed with SLA since the last time I was here. We will just end up arguing old ground if I comment.

Oh wait, there is one thing that has changed. SLA decided not to release their results when the patents came through. Surprising that! You really have to wonder how well their products actually do work, don't you. Before you say, "oh, but it would stop them publishing their results in a journal", I will tell you that academic and commercial researchers publish abstracts, give talks and present quite detailed posters on research they will later publish in respected journals every single day and I cannot think of a single journal that doesn't allow this. A relatively detailed abstract is basically all that the ASX code of best practice for reporting of life science companies requires. Next SLA will tell you that Peter Stedwell is an independent director - oops wait, they already did.

Cheers,

Bill